Procoagulant potential of platelet α granules

Platelets

Volumn 15, Issue 7, 2004, Pages 403-407

  Polasek, J ^a,b  

^a William Osler Health Center   (Canada)

^b NONE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; AMINOPHOSPHOLIPID; BLOOD CLOTTING FACTOR 5; CD63 ANTIGEN; FIBRINOGEN RECEPTOR; LIPOCORTIN 5; PADGEM PROTEIN; PROCOAGULANT; THROMBOPLASTIN;

APOPTOSIS; BLOOD CLOTTING; CELL GRANULE; CELL MEMBRANE; DEGRANULATION; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; LYSOSOME; PLATELET ALPHA GRANULE; PRIORITY JOURNAL; PSEUDOPODIUM; SHORT SURVEY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CYTOPLASMIC GRANULES; HUMANS; PLATELET ACTIVATION;

PSEUDOPODA;

EID: 8744244550     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100410001721315     Document Type: Short Survey

References (52)

1. Fantl P, Ward H A. The thromboplastic component of intact blood platelets is present in masked form. Aust J Exp Biol Med Sci 1958; 36: 499-504.
2. Joist J H, Dolezel G, Lloyd J V, Kinlough-Rathbone R L, Mustard J F. Platelet factor 3 availability and the platelet release reaction. J Lab Clin Med 1974; 84: 474-82.
3. Heemskerk J W M, Bevers E M, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-93.
4. Solum N O. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999; 23: 2841-6.
5. Polasek J. Particulate nature of acid phosphatase released from platelets. Thromb Diath Haemorrh 1968; 19: 466-73.
6. Polasek J, Kubisz P. Acid phosphatases and platelet factor 3. Scand J Haematol 1968; 5: 390-400.
7. Marcus A J, Zucker-Franklin D, Safier L B, Ullman H L. Studies on platelet granules and membranes. J Clin Invest 1966; 45: 14-28.
8. Morgenstern E. The pathway of exocytosis in human platelets. Blood 1998; 92: 2191-2.
9. Polasek J, Richardson M, Moore M A, Blajchman M J. Evidence for an alternate mechanism of platelet secretion involving peripheralization of secretory granules and formation of membrane associated multivesicular structures. Thromb Res 1987; 45: 771-82.
10. Polasek J. Lysosomal concept of platelet secretion-revisited. Eur J Haematol 1989; 43(Suppl 50): 1-24.
11. Sandberg H, Anderson L O, Hoglund S. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets. Biochem J 1982; 203: 303-11.
12. Hughes M, Hayward C P M, Warkentin T E, Horsewood P, Chorneyko K A, Kelton J G. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-94.
13. Swords N A, Tracy P B, Mann K G. Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. Arterioscler Thromb 1993; 13: 1613-22.
14. Sims P J, Faioni E M, Wiedmer T, Shattil S J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
15. Dachary-Prigent J, Pasquet J M, Freyssinet J M, Nurden A T. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry 1995; 34: 11625-34.
16. Holme P A, Solum N O, Brosstad F, Egberg N, Lindahl T L. Stimulated Glanzmann's thrombasthenia platelets produce microvesicles. Thromb Haemost 1995; 74: 1533-40.
17. Jy W, Horstman, Wang F, Duncan R C, Ahn Y S, Harrington W J Sr. Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. Thromb Res 1995; 80: 471-82.
18. Ilveskero S, Siljander P, Lassila R. Procoagulant activity on platelets adhered to collagen or plasma clot. Arterioscler Thromb Vasc Biol 2001; 21: 628-35.
19. Stuart MCA, Bevers E M, Comfurius P, Zwaal R F A, Reutelingsperger C P M, Frederik P M. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets. Thromb Haemost 1995; 74: 1145-51.
20. Escolar G, Rao G H, Nieuwenhuis H K, White J G. Ultrastructural expression of P-selectin on surface activated platelets. Platelets 1996; 7: 297-301.
21. Heemskerk J W M, Vuist W M J, Feijge M A H, Reutelingsperger Ch P M, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: Evidence for regulation by protein tyrosine kinase-dependent Ca responses. Blood 1997; 90: 2615-25.
22. Heemskerk J W M, Siljander P, Vuist W M J, Breikers G, Reutelingsperger Ch P M, Barnes M J, Knight C G, Lassila R, Farndale R W. Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets. Thromb Haemost 1999; 81: 782-92.
23. Briede J J, Heemskerk JWM, Hemker H C, Lindhout T. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. Biochim Biophys Acta 1999; 1451: 163-72.
24. Thon I L, Uvnas B. Degranulation and histamine release, two consecutive steps in the response of rat mast cells to compound 48/80. Acta Physiol Scand 1967; 71: 303-15.
25. Demo S D, Masuda E, Rossi A B, Throndset B T, Gerard A L, Chan E H, Armstrong R J, Fox B P, Lorens J B, Payan D G, Scheller R H, Fisher J M. Quantitative measurement of mast cell degranulation using a novel flow cytometric Annexin-V binding assay. Cytometry 1999; 36: 340-8.
26. Grinstein S, Furuya W. Intracellular distribution of acridine derivatives in platelets and their suitability for cytoplasmic pH measurements. Biochim Biophys Acta 1984; 803: 221-8.
27. Gogstad G O. A method for the isolation of alpha granules from human platelets. Thromb Res 1981; 20: 669-81.
28. Harrison P, Wilbourn B, Debili N, Vainchenker W, Breton-Gorius J, Lawrie A S, Masse J M, Savidge G F, Cramer E M. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 1989; 84: 1320-4.
29. Handagama P J, Shuman M A, Bainton D F. Incorporation of intravenously injected albumin, immunoglobulin G and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest 1989; 84: 73-82.
30. Camire R M, Pollak E S, Kaushansky K, Tracy P B. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998; 92: 3035-41.
31. Heijnen HFG, Debili N, Vainchencker W, Breton-Gorius J, Geuze H J, Sixma J J. Multivesicular bodies are an intermediate stage in the formation of platelet alpha granules. Blood 1998; 91: 2313-25.
32. Andrews N W. Regulated secretion of conventional lysosomes. Trends Cell Biol 2000; 10: 316-21.
33. Kinlough-Rathbone R L, Packham M A, Guccione M A, Richardson M, Harfenist E J, Mustard J F. Characteristics of thrombin degranulated human platelets: Development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemost 1991; 65: 403-10.
34. Olas B, Lundell K, Holmsen H, Fukami M H. Biochemical properties of platelet microparticle membranes formed during exocytosis resemble organelles more than plasma membrane. FEBS Lett 2002; 525: 29-32.
35. Polasek J, Duckert F. Diagnosis of quinidine hypersensitivity. Use of platelet factor 3 and acid phosphatase availability tests. Acta Haematol (Basel) 1971; 45: 356-64.
36. Wiedmer T, Shattil S J, Cunningham M, Sims P J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29: 623-32.
37. Weiss H J. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol 1994; 31: 312-9.
38. Sims P J, Wiedmer T, Esmon C T, Weiss H J, Shatil S J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
39. van Heerde W L, de Groot P G, Reutelingsperger Ch P M. The complexity of the phospholipid binding protein Annexin V. Thromb Haemost 1995; 73: 172-9.
40. Thiagarajan P, Benedict C R. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997; 6: 2339-47.
41. Brunk U T, Svenssoni I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep 1999; 4: 3-11.
42. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Different 2001; 8: 569-81.
43. Fernandez-Segura E, Canizares F J, Cubero M A, Warley A, Campos A. Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis. Exp Cell Res 1999; 253: 454-62.
44. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001; 88: 998-1003.
45. Wang J, Weiss I, Svoboda K, Kwaan H C. Thrombogenic role of cells undergoing apoptosis. Br J Haematol 2001; 115: 382-91.
46. Zillmann A, Luther T, Müller I, Kotzsch M, Spannagl M, Kauke T, Oelschlägel U, Zahler S, Engelmann B. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281: 603-9.
47. Siddiqui F A, Desai H, Amirkhosravi A, Amaya M, Francish J L. The presence and release of tissue factor from human platelets. Platelets 2002; 13: 247-53.
48. Giesen P L A, Rauch U, Bohrmann B, Kling D, Roque M, Fallon J T, Badimon J J, Himber J, Riederer M A, Nemerson Y. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
49. Carson S D, Pirruccello S J. Immunofluorescent studies of tissue factor on U87MG cells: evidence for non-uniform distribution. Blood Coagul Fibrinolysis 1993; 4: 911-20.
50. Lewis J C, Bennett-Cain A L, DeMars C S, Doellgast G J, Grant K W, Jones N L, Gupta M. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol 1995; 147: 1029-40.
51. Hansen C B, van Deurs B, Petersen L C, Rao L V. Discordant expression of tissue factor and its activity in polarized epithelial cells. Asymmetry in anionic phospholipid availability as a possible explanation. Blood 1999; 94: 1657-64.
52. Vanags D M, Orrenius S, Aguilar-Santelises M. Alterations in Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis. Br J Haematol 1997; 99: 824-31.